Skip to main content
Clinical Trials/CTRI/2019/07/020404
CTRI/2019/07/020404Not yet recruiting未知

A pilot study to estimate prevalence of Celiac disease in high risk-group in Asia (Asian celiac disease Study)

Takeda Pharmaceutical Company Limited0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Inclusion Criteria

  • 1. Age 18-60
  • 2. Both genders
  • 3. Willing to participate
  • 4. Patients with Irritable Bowel Syndrome (IBS) and 5. Functional Dyspepsia (FD) as per Rome IV criteria

Exclusion Criteria

  • 1. Previously diagnosed cases of celiac disease
  • 2. Patients on Gluten free diet
  • 3. Refusal to provide consent
  • 4. Pregnant women
  • 5. HIV positive patients
  • 6. Chronic NSAID intake
  • 7. Active smoking
  • 8. Inflammatory bowel disease
  • 9. Dysmorphic features and disproportionate short stature
  • 10. Comorbid severe conditions - pulmonary, renal, liver, cardiac, chronic illness and medication

Investigators

Similar Trials